Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Similar documents

PHARMACY PEARLS CHANIN WRIGHT, PHARMD

Hazardous Medication List

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

MEDICAL NECESSITY GUIDELINE

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site

Emetogenicity level 1. Emetogenicity level 2

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients

DRUG PROPERTIES YOU NEED TO KNOW

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

Guidelines for the Use of Anti-Emetics with Chemotherapy

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!

1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation.

DRUGS YOU NEED TO KNOW

1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and

APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer

Managements of Chemotherpay Induded Nausea and Vomiting

1. Purpose Documentation Description.1 4. References 8 5. Cross-References.8 6. Development of the guideline.8

Adult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY

Supplementary Figures

Description The following are synthetic cannabinoids requiring prior authorization: dronabinol (Marinol, Syndros ), nabilone (Cesamet )

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days

Title Developed By. Implementation Contact person(s) Review Date Group Responsible. NICaN Policy: Management of Chemotherapy Extravasation; Version 3

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class

DRUG PROPERTIES YOU NEED TO KNOW

Committee Approval Date: December 12, 2014 Next Review Date: July 2015

Subject: Palonosetron Hydrochloride (Aloxi )

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

Part B payment for drugs in Medicare 0

AD regimen, 576 adrenal steroid inhibitor. aminoglutethimide, 23 25

OVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY)

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

Exposure Control Plan for Cytotoxic Substances

Job title: Consultant Pharmacist/Advanced Practice Pharmacist

CHEMOTHERAPY/ ANTICANCER DRUGS/ NEOPLASTIC AGENTS

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care

Acute Lymphocytic Leukemia

Part B payment for drugs in Medicare 0

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

MASCC Guidelines for Antiemetic control: An update

Haematology, Oncology and Palliative Care Directorate.

Chemotherapy 101 for Radiation Oncology Workers

ECN Protocol Book. Guidelines on the management of extravasation. ECN_Protocol_Book_extravasation guidelines_2

Clinical Tools and Resources for Self-Study and Patient Education

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1

Current and Emerging Therapeutic Options in the Management of Chemotherapy-Induced Nausea and Vomiting (CINV) Objectives

1 SpringerWienNewYork

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

Introduction to Antineoplastic Prescribing

The AngCN Antiemetic Guidelines

DRUG EXTRAVASATION. Vesicants. Irritants

See Important Reminder at the end of this policy for important regulatory and legal information.

Prevention and Management of chemo-and radiotherapy-induced nausea and vomiting

Subject: Fosnetupitant-Palonosetron (Akynzeo) IV

Guideline Update on Antiemetics

See Important Reminder at the end of this policy for important regulatory and legal information.

ANTIEMETICS UTILIZATION MANAGEMENT CRITERIA

FOR A HIGHER DEGREE OF CONFIDENCE

8. Malignant disease and immunosuppression

Vasco OP Underglove Sterile Surgical and Protective Gloves

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

Antiemetic Guidelines. Guidelines for the Management of Nausea and Vomiting in Adult Patients Receiving Chemotherapy and/or Radiotherapy

REVIEW Guideline for the Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients

Corporate Medical Policy

ECN Protocol Book. Antiemetic Guidelines for Adult Patients Receiving Chemotherapy and Radiotherapy

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

Recognising and reducing the risk of chemotherapy extravasation

Guidelines for the Management of Extravasation (Version 5 May 2012)

Additional information to support. The National Patient Safety Agency s Rapid Response Report Risks of incorrect dosing of oral anti-cancer medicines

Chemotherapy extravasation guideline

ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER

ONCOLOGY AND HAEMATOLOGY TREATMENT CENTRE Quality System Guidelines For The Safe Delivery of Systemic Anti Cancer Therapy

Vasco OP Free Sterile Surgical and Protective Gloves

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

Vasco OP Sensitive Sterile Surgical and Protective Gloves

An introduction to the Essential Medicines concept: balancing innovation with public health priorities

Guidelines for the Management of Extravasation

Systemic Anti-cancer Therapy Care Pathway Guidelines for the management of SACT induced nausea and vomiting in adult patients

Cytostatics Definition, Terminology

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS

Standard Regimens for Haematology

Guidelines for prevention and management of CHEMOTHERAPY EXTRAVASATION

Disclosure. Objectives. Objectives. Oncologic Emergency. Classification of Emergencies 1 3/2/2015

Systemic Anticancer Therapy Drug Interactions Table

Working Formulary January 2013 Oncology Chemotherapy Regimens

CHEMOTHERAPY NETWORK GROUP POLICY FOR THE MANAGEMENT

INDEX. Note: Page numbers followed by f indicate figures; page numbers followed by t indicate tables.

This PDF is available for free download from a site hosted by Medknow Publications

Ovarian Cancer. compendia TREATMENT OF

Form 2023 R2.0: Ovarian Cancer Pre-HSCT Data

Transcription:

WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black Country Partnership Foundation Trust (BCPFT) Pharmacy staff Medicines no longer required which have been dispensed by the SLA Pharmacy provider and transferred with the patient, not leaving hospital premises, and still in date, may be recycled. Any medicines that are no longer required and cannot be recycled MUST be disposed of in the appropriate pharmacy waste bin (Please see the Trust s up to date waste policy for the appropriate coloured lidded bin. Appendix A is a list of Hazardous medicines that extra care is needed with). This includes Patient s Own Drugs (PODs) only after completion of Patients Own Medicines Destruction Consent Form. See Standard Operating No. using Patients own Drugs. : 1. At each trolley/caddy check, medicines no longer required which have been supplied by BCPFT, must be removed from either the patient caddy or the medicines trolley. If this medication has not left the hospital premises and been supplied by the SLA Pharmacy Provider, it may be recycled for use by another patient, if found in suitable condition. Check that the medication is in date and suitable for use. Put into pharmacy pre-integrity checking box/drawer in pharmacy for later use and do not remove the dispensed label. The box/drawer containing the drugs for recycling in pharmacy needs to be emptied on a regular basis. Each medicine needs to be integrity checked by a band 5 technician or above (checking the medicine is in date and establishing its safety and suitability for re-use). Once the integrity check has been completed the medicine can then be placed into the post integrity checked receptacle/drawer and the medicines can then be accessed by the band 3 pharmacy assistant and booked into the folder and secured in the medicine cupboards for future use.

WARDS/DEPARTMENT By: 0 01/09/019 of 3. Enter the following details in the Stock Control folder on the appropriate alphabetised sheet:- Date The ward the medicine has been returned from (if available) Drug name (including strength and form) Quantity Batch number and expiry date 3. After booking in, store the medication in alphabetical order in the cupboard (all medication must be stored in the lockable medicine cupboard and not left in the office). Medicines must be used in date order. 4. When re-issuing medication, find the correct entry in the Stock Control folder and book out the item by completing the Date and issued to box on the log sheet. 5. If and when this item of medication is required for use for another patient or for ward use then apply a new label over the old label before issuing to the ward (apply new label without covering the name and address of original provider) 6. Any out of date medicines, medicines not suitable for use and PODs no longer required by the patient should be disposed of on the wards/department by placing in their original packaging into the appropriate pharmacy waste bin. 7. Make sure hazardous medicines go into the appropriate waste bin. 8. Patient s own medication no longer required may be disposed of after completion of Disposal of Patient s own Medicines Form (Refer to Sop No using Patients Own Drugs). The completed form must then be filed in the patient s notes, or in the pharmacy if notes have been filed. 9. At the end of each month the costing for all medicines recycled needs to be totalled. This establishes the savings the pharmacy department have made. Working through the recycling folder a list can be made of each medication recycled and the quantity recycled. 10. Once the list of names of medication and quantities have been logged down on a piece of paper somewhere then you need to access the Drug Tariff on line.

WARDS/DEPARTMENT By: 0 01/09/019 3 of 3 To access the Drug Tariff online you need to open the following link http://www.nhsbsa.nhs.uk/prescriptionservices/4940.aspx and scroll down to the appropriate month. Open up the Adobe PDF file and on the left hand side of page and scroll down to the link Part VIIIA Basic Prices of Drugs. Expand the link. Once the page has opened scroll down to your required medication the price quoted will be for an original pack size so take precaution to work out the sum if a part pack was recycled. For example Lansoprazole 30mg for a pack of 8 is 3.48 so if 1 was recycled you would use the sum 3.48 8 = 0.14 x 1 =.60

Appendix A. Taken from the Safe Management of Healthcare Waste 1 www.dh.gov.uk This list is not exhaustive and may not include all very new, unlicensed or trial medicines List of Hazardous medicines. Aldesleukin Dactinomycin Alemtuzumab Danazol Alitretinoin Daunorubicin Hcl Altretamine Dasatinib Amsacrine Denileukin Anastrazole Dienestrol Arsenic trioxide Diethylstilbestrol Asparaginase Dinoprostone Azacitidine Dithranol Azathioprine Docetaxel Bacillus Calmette-Guerin Vaccine Doxorubicin Bexarotene Dutasteride Bicalutamide Epirubicin Bleomycin Ergometrine/methylergometrine Bortezomib Estradiol Busulfan Estramustine phosphate sodium Capecitabine Estrogen-progestin combinations Carboplatin Estrogens, conjugated Carmustine Estrogens, esterified Cetuximab Estrone Cetrorelix Acetate Estropipate Chlorambucil Etoposide Chloramphenicol Exemestane Chlormethine hydrochloride Finasteride Choriogonadotropin alfa Floxuridine Cidofovir Fludarabine Coal tar containing preps Fluorouracil Cisplatin Fluoxymesterone Cladribine Flutamide Colchicine Fulvestrant Ciclosporin Ganciclovir Cyclophosphamide Ganirelix acetate Cytarabine Gemcitabine Dacarbazine Gemtuzumab ozogamicin Goserelin Hydroxcarbamide

Cont. Ibritumomab tiuxetan Raloxifene Idarubicin Raltitrexed Ifosfamide Ribavirin Imatinib mesilate Rituximab Interferon containing products (including peginterferon) Sirolimus Irinotecan HCL Streptozocin Leflunomide Tacrolimus Letrozole Tamoxifen Leuprorelin acetate Temozolomide Lomustine Teniposide Megestrol Testolacton Menotropins Testosterone Mercaptopurine Thalidomide Melphalan Tioguanine Methotrexate Thiotepa Methyltestosterone Toremifene citrate Mifepristone Topotecan Mitomycin Tositumomab Mitotane Tretinoin Mitoxantrone HCL Trifluridine Mycophenolate mofetil Trimetrexate glucuronate Nafarelin Triptorelin Nilutamide Uramustine Oestrogen containing products Valganciclovir Oxaliplatin Valrubicin Oxytocin Vidarabine Paclitaxel Vinblastine sulphate Pegaspargase Vincristine sulphate Pentamidine isethionate Vindesine Pentostatin Vinorelbine tartrate Perphosphamide Zidovudine Pipobroman Piritrexim isethionate Plicamycin Podoflilox Podophyllum resin Prednimustine Procarbazine Progesterone Progestins